Vestcor Inc grew its position in Maximus, Inc. (NYSE:MMS - Free Report) by 85.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,197 shares of the health services provider's stock after acquiring an additional 7,900 shares during the quarter. Vestcor Inc's holdings in Maximus were worth $1,602,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of the business. Barclays PLC grew its position in Maximus by 285.1% during the 3rd quarter. Barclays PLC now owns 170,971 shares of the health services provider's stock worth $15,927,000 after purchasing an additional 126,573 shares during the last quarter. Public Employees Retirement System of Ohio acquired a new stake in shares of Maximus during the third quarter worth about $159,000. Y Intercept Hong Kong Ltd purchased a new position in shares of Maximus during the third quarter worth about $1,008,000. MML Investors Services LLC increased its position in Maximus by 6.5% in the 3rd quarter. MML Investors Services LLC now owns 4,870 shares of the health services provider's stock valued at $454,000 after acquiring an additional 299 shares during the period. Finally, XTX Topco Ltd increased its position in Maximus by 234.1% in the 3rd quarter. XTX Topco Ltd now owns 11,879 shares of the health services provider's stock valued at $1,107,000 after acquiring an additional 8,324 shares during the period. 97.21% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, StockNews.com downgraded Maximus from a "buy" rating to a "hold" rating in a report on Thursday, November 28th.
Read Our Latest Stock Analysis on MMS
Insiders Place Their Bets
In related news, insider Michelle F. Link sold 2,208 shares of the stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total value of $163,016.64. Following the sale, the insider now directly owns 6,567 shares of the company's stock, valued at approximately $484,841.61. This represents a 25.16 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.40% of the stock is currently owned by company insiders.
Maximus Price Performance
Shares of MMS traded down $0.39 during mid-day trading on Thursday, hitting $70.67. The company's stock had a trading volume of 621,849 shares, compared to its average volume of 431,204. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59. Maximus, Inc. has a 1-year low of $70.00 and a 1-year high of $93.97. The firm has a market capitalization of $4.26 billion, a P/E ratio of 14.21 and a beta of 0.73. The firm has a 50-day simple moving average of $83.41 and a 200 day simple moving average of $86.81.
Maximus Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Saturday, November 30th. Investors of record on Friday, November 15th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.70%. The ex-dividend date was Friday, November 15th. Maximus's dividend payout ratio is currently 24.00%.
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.